Massive parallel sequencing for molecular-genetic diagnosis of mental retardation

Levchenko O.A.; Lavrov A.V.

doi:https://doi.org/10.17116/jnevro201811812165

Close metadata

Recommended articles:

Genome instability of the cholera agent: role in the evolution of pathogenicity, drug resistance and adaptation to a changing environment. Molecular Genetics, Microbiology and Virology. 2025;(2):3-13

Machine learning models for brain tumors differential diagnosis. Russian Journal of Preventive Medicine. 2025;(9):87-93

Coronaviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Molecular Genetics, Microbiology and Virology. 2025;(4-2):55-63

News in molecular biology. Digest of scientific publications. Issue 2. Laboratory Service. 2025;(4):5-7

Application of a targeted panel to search for genetic variants of hereditary breast cancer. P.A. Herzen Journal of Oncology. 2026;(1):18-23

Results of the multicenter study “Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 1. Molecular genetic characteristics of inherited retinal pathologies. Russian Annals of Ophthalmology. 2026;(1):70-78

Results of the multicenter study “Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 2. Clinical, social and demographic characteristics of inherited retinal pathologies. Russian Annals of Ophthalmology. 2026;(1):79-86

Abstract:

Gene mutations occur with high frequency in children with mental retardation. Standard diagnostic methods, such as TMS, Sanger’s sequencing of individual genes, MLPA analysis of deletions, and investigation of methylation status in Martin—Bell syndrome are not informative in the majority of cases that hampered further diagnostic efforts. Massive parallel sequencing (MPS) allowed physicians to continue diagnostic search in previously undiagnosed cases and to find molecular causes of disease. MPS permits to discover a large number of new genes and understand the pathogenesis of mental retardation and brain development more deeply. It became possible to perform prenatal and pre-implantation diagnostics. However, big data generate big problems with their interpretation the genetic counselor faces with. This review reflects the advantages and disadvantages of MPS. Different variants of MPS, including gene panels, whole exome and whole genome sequencing as well as sequencing of trios, are described. In addition, the authors discuss the difficulties of interpretation of the results and recommendations for obtaining the most accurate results.

Keywords:

mental retardation

next-generation sequencing

exome

genome

gene panels

whole genome sequencing

Authors:

Levchenko O.A.

Research Centre for Medical Genetics, Moscow, Russia

Lavrov A.V.

Research Centre for Medical Genetics, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Close metadata

References:

Carulla LS, Reed GM, Vaez-Azizi LM, Cooper S-A, Leal RM, Bertelli M, Adnams C, Cooray S, Deb S, Dirani LA, Girimaji SC, Katz G, Kwok H, Luckasson R, Simeonsson R, Walsh C, Munir K, Saxena, S. Intellectual developmental disorders: towards a new name, definition and framework for «mental retardation/intellectual disability» in ICD-11. World Psychiatry. 2011;10(3):175-180. https://doi.org/10.1002/j.2051-5545.2011.tb00045.x
Heather C Mefford, Mark L Batshaw, Eric P. Hoffman. Genomics, Intellectual Disability, and Autism. N Engl J Med. 2012;366(8):733-743. https://doi.org/10.1056/nejmc1204397
Sadock BJ, Sadock V, Ruiz P. Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
Leonard H, Wen X. The epidemiology of mental retardation: Challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev. 2002;8(3):117-134. https://doi.org/10.1002/mrdd.10031
Mercadante MT, Evans-Lacko S, Paula CS. Perspectives of intellectual disability in Latin American countries: epidemiology, policy, and services for children and adults. Curr Opin Psychiatry. 2009;22(5):469-474. https://doi.org/10.1097/yco.0b013e32832eb8c6
Fombonne E. Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders : An Update. J Autism Dev Disord. 2003;33(4):365-382. https://doi.org/10.1017/cbo9780511544446.003
Fombonne E. Epidemiology of Pervasive Developmental Disorders. Pediatr Res 2009;65(6):591-598. https://doi.org/10.1093/med/9780195371826.003.0007
Vissers LELM, Ligt de J, Gilissen C, Janssen I, Steehouwer M, De Vries P, Lier BV, Arts P, Wieskamp N, Rosario M, Van Bon BVM, Hoischen A, De Vreis BBA, Brunner HG, Veltman, JA. A de novo paradigm for mental retardation. Nat Pub Gr Nature Publishing Group. 2010;42(12):1109-1112. https://doi.org/10.1038/ng.712
Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet. 2006;14(6):701-713. https://doi.org/10.1038/sj.ejhg.5201595
Schaefer GB, John B Bodensteiner. Evaluation of the Child with Mental Retardation. Pediatr Neurol Elsevier Masson SAS. 1992;39(4):929-943. https://doi.org/10.1016/s0031-3955(16)38381-x
Curry CJ, Stevenson R E, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham GM Jr, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz, J. Evaluation of Mental Retardation: Recommendations of a consensus conference. Am J Med Genet. 1997;72(4):468-477. https://doi.org/10.1002/(sici)1096-8628(19971112)72:4<468::aid-ajmg18>3.0.co;2-p
Waltereit R, Banaschewski T, Meyer-lindenberg A, Poustka L. Interaction of neurodevelopmental pathways and synaptic plasticity in mental retardation, autism spectrum disorder and schizophrenia: Implications for psychiatry. World J Bio Psychiatry. 2014;15(7):507-516. https://doi.org/10.3109/15622975.2013.838641
Gillberg C, Persson E, Grufman M, Themner U. Psychiatric Disorders in Mildly and Severely Mentally Retarded Urban Children and Adolescents: Epidemiological Aspects. Br J Psychiatry. 1986;149(1):68-74. https://doi.org/10.1192/bjp.149.1.68
Ropers H-H, Hamel BCJ. X-linked mental retardation. Nat Rev Genet. 2005;6(1):46-57. https://doi.org/10.1038/nrg1501
Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Gene. Dev. 2007;17(3):182-192. https://doi.org/10.1016/j.gde.2007.04.009
Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, Firth H, Sanlaville D, Winter R, Colleaux L, Bobrow M, Carter NP. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet. 2004;41(4):241-248. https://doi.org/10.1136/jmg.2003.017731
Iourov IY, Vorsanova SG. Kurinnaia OS, Zelenova MA, Silvanovich AP, Yurov YB. Molecular karyotyping by array CGH in a Russian cohort of children with intellectual disability, autism, epilepsy and congenital anomalies. Mo Cytogenet. 2012;5(1):46-55. https://doi.org/10.1186/1755-8166-5-46
Vorsanova SG, Iourov IY, Kurinnaya OS, Voinova VY, Yurov YB. Genomnye anomalii u detei s umstvennoi otstalost’yu i autizmom: ispol’zovanie tekhnologii sravnitel’noi genomnoi gibridizatsii na khromosomakh in situ (HRCGH) i molekulyarnogo kariotipirovaniya na DNK-mikromatritsakh (array CGH). Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(8):46-49. (In Russ.)
Lavrov AV, Bannikov AV, Chausheva AI, Dadali EL. Genetika umstvennoi otstalosti. Rossiiskii Vestnik Perinatologii i Pediatrii. 2016;61(6):13-20. (In Russ.) https://doi.org/10.21508/1027-4065-2016-61-6-13-20
Xue Y, Ankala A, Wilcox WR, Hegde MR. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med. 2015;17(6):444. https://doi.org/10.1038/gim.2014.122
Hamdan FF, Gauthier J, Araki Y, Lin D, Yoshizawa Y, Higashi K, Tomitori H, Park A-R, Spiegelman D, Dobrzeniecka S, Daoud H, Massicotte C, Henrion E, Diallo O, Group S2D, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, D’Anjou G, Vanasse M, Srour M, Lafrenie GL, Drapeau P, Lacaille JC, Kim E, Lee J-R, Igarashi K, Huganir RL, Rouleau GA, Michaud JL. Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability. Am J Hum Genet. 2011;88(3):306-316. https://doi.org/10.1016/j.ajhg.2011.03.011
Redin C, Gérard B, Lauer J, Herenger Y, Muller J, Quartier A, Masurel-Paulet A, Willems M, Lesca G, El-Chehadeh S, Le Gras S, Vicaire S, Philipps M, Dumas M, Geoffroy V, Feger C, Haumesser N, Alembik Y-V, Barth M, Bonneau D, Colin E, Dollfus H, Doray B, Delrue M-A, Drouin-Garraud V, Flori E, Fradin M, Francannet C, Goldenberg A, Lumbroso S, Mathieu-Dramard M, Martin-Coignard D, Lacombe D, Morin G, Polge A, Sukno S, Thauvin-Robinet C, Thevenon J, Doco-Fenzy M, Genevieve D, Sarda P, Edery P, Isidor B, Jost B, Olivier-Faivre L, Mandel J-L, Piton A. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet. 2014;51(11):724-736. https://doi.org/10.1136/jmedgenet-2014-102554
Tzschach A, Grasshoff U, Beck-woedl S, Dufke C, Bauer C, Kehrer M, Evers C, Moog U, Oehl-jaschkowitz B, Di Donato N, Maiwald R, Jung K, Kuechler A, Schulz, Meinecke P, Spranger S, Kohlhase J, Seidel J, Reif S, Rieger M, Riess A, Sturm M, Bickmann J, Schroeder C, Dufke A, Riess O, Bauer P. Next-generation sequencing in X-linked intellectual disability. Eur J Hum Genet. 2015;23(11):1513-1518. https://doi.org/10.1038/ejhg.2015.5
Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, Hosseini M, Behjati F, Haas S, Jamali P, Zecha A, Mohseni M, Pu L, Vahid LN, Jensen C, Moheb LA, Bienek M, Larti F, Mueller I, Weissmann R, Darvish H, Wrogemann K, Hadavi V, Lipkowitz B, Esmaeeli-nieh S, Wieczorek D, Hertzberg C, Dehghan A, Rajab A, Javad M, Banavandi S, Hoffer J, Falah M, Ropers HH. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478(7367):2-8. https://doi.org/10.1038/nature10423
Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, Das K, Toy T, Harr, B, Yourshaw M, Fox M, Fogel BL, Martinez-Agost, JA, Wong DA, Chang VY, Shieh PB, Palmer CGS, Dipple KM, Grody WW, Vilain E, Nelson SF. Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders. JAMA. 2014;312(18):1880-1887. https://doi.org/10.1001/jama.2014.14604
Ng SB, Turner EH, Robertson PD, Flygare SD, Abigail W, Lee C, Shaffer M, Wong M, Bhattacharjee A, Evan E, Bamshad M, Nickerson DA, Shendure J. Targeted Capture and Massively Parallel Sequencing of twelve human exomes. Nature. Nature Publishing Group. 2010;461(7261):272-276. https://doi.org/10.1038/nature08250
De Ligt J, Willemsen MH, Van Bon BWM, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, De Vries P, Gilissen C, Del Rosario M, Hoischen A, Scheffer H, De Vries BBA, Brunner HG, Veltman JA. Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability. N Engl J Med. 2012;367(20):1921-1929. https://doi.org/10.1111/cch.12034
Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Science Translational Medicine. 2014;6(256):265ra168. https://doi.org/10.1126/scitranslmed.3010076
Gilissen C, Hehir-kwa JY, Thung DT, Vorst M Van De, Bon, B. W. M. Van, Willemsen MH, Kwint M, Janssen IM, Hoischen A, Schenck A, Leach R, Klein R, Tearle R, Bo T, Pfundt R, Yntema HG, De Vrie, BBA, Kleefstra T, Brunner HG, Vissers LELM, Veltman JA. Genome sequencing identifies major causes of severe intellectual disability. Nature. Nature Publishing Group. 2014;511(7509):344. https://doi.org/10.1038/nature13394
Bell J, Bodmer D, Sistermans E, Ramsden S. Practice guidelines for the interpretation and reporting of unclassified variants (UVs) in clinical molecular genetics. CMGS. 2007. Accessed October 10, 2017. http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.530.3144
Wallis Y, Payne S, Mcanulty C, Bodmer D, Sister-mans E, Robertson K, Moore D, Abbs S, Deans Z, Devereau A. Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics. ACGS. 2013. Accessed October 10, 2017. http://www.acgs.uk.com/media/774853/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-423. https://doi.org/10.1038/gim.2015.30
Ryzhkova OP, Kardymon OL, Prokhorchuk EB, Konovalov FA, Maslennikov AB, Stepanov VA, Afanas’ev AA, Zaklyaz’minskaya EV, Kostareva AA, Pavlov AE, Golubenko MV, Polyakov AV, Kutsev SI. Rukovodstvo po interpretatsii dannykh, poluchennykh metodom massovogo parallel’nogo sekvenirovaniya (MPS). Meditsinskaya Genetika. 2016;16(7):4-17. (In Russ.)
Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani C, Claustres M, Cuppens H, Georges M, Ferec C, Macek M, Pignatti P-F, Scheffer H, Schwartz M, Witt M. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders — updated European recommendations. Eur J Hum Genet. 2009;17(1):51-65. https://doi.org/10.1038/ejhg.2008.136
Schuurs-hoeijmakers JHM, Silfhout ATV, Vissers LELM, Van de Vondervoort IIGM, Van Bon BVM, De Ligt J, Gilissen C, Hehir-Kwa JY, Neveling K, Rosario M, Hira G, Reitano S, Vitello A, Failla P, Greco D, Fichera M, Galesi O, Kleefstra T, Greally MT, Ockeloen CW, Willemsen MH, Bongers EMHF, Janssen IM, Pfundt R, Veltman JA, Romano C, Willemse MA, Van H, Brunner HG, De Vries BBA, De Brouwer APM. Identification of pathogenic gene variants in small families with intellectually di sabled siblings by exome sequencing. J Med Genet. 2013;50(12):802-811. https://doi.org/10.1136/jmedgenet-2013-101644
Plon SE, Eccles DM, Easton D, Foulkes WD, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2011;29(11):1282-1291. https://doi.org/10.1002/humu.20880
Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer J Mol Diagnostics. 2017;19(1):4-23. https://doi.org/10.1016/j.cancergen.2017.04.015
Harripaul R, Noor A, Ayub M, Vincent JB. The Use of Next-Generation Sequencing for Research and Diagnostics for Intellectual Disability. Cold Spring Harb Perspect Med. 2017;7(3):a026864. https://doi.org/10.1101/cshperspect.a026864
Vissers LELM, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 2015;17(1):9-18. https://doi.org/10.1038/nrg3999
Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68-74. https://doi.org/10.1038/nature15393
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghou, J, Cooper DN, Deflaux N, DePristo M, Do R, Flannic, J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won H-H, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285-291. https://doi.org/10.1038/nature19057
Hamdan FF, Srour M, Capo-Chichi J.-M, Daoud H, Nassif C, Patry L, Massicotte C, Ambalavanan A, Spiegelman D, Diallo O, Henrion E, Dionne-Laporte A, Fougerat A, Pshezhetsky AV, Venkateswaran S, Rouleau GA, Michaud JL. De Novo Mutations in Moderate or Severe Intellectual Disability. PLoS Genet. 2014;10(10):e1004772. https://doi.org/10.1371/journal.pgen.1004772
Stessman HAF, Xiong B, Coe BP, Wang T, Hoekzema K, Fenckova M, Kvarnung M, Gerdts J, Trinh S, Cosemans N, Vives L, Lin J, Turner TN, Santen G, Ruivenkamp C, Kriek M, Van Haeringen A, Aten E, Friend K, Liebelt J, Barnett C, Haan E, Shaw M, Gecz J, Anderlid B-M, Nordgren A, Lindstrand A, Schwartz C, Kooy RF, Vandeweyer G, Helsmoortel C, Romano C, Alberti A, Vinci M, Avola E, Giusto S, Courchesne E, Pramparo T, Pierce K, Nalabolu S, Amaral DG, Scheffer IE, Delatycki MB, Lockhart PJ, Hormozdiari F, Harich B, Castells-Nobau A, Xia K, Peeters H, Nordenskjöld M, Schenck A, Bernier RA, Eichler EE. Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nat Genet. 2017;49(4):515-526. https://doi.org/10.1038/ng.3792
Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes. PLoS Genet. 2013;9(8):e1003709. https://doi.org/10.1371/journal.pgen.1003709
Ashktorab H, Azimi H, Nickerson ML, Bass S, Varma S, Brim H. Targeted Exome Sequencing Outcome Variations of Colorectal Tumors within and across Two Sequencing Platforms. J Next Gener Seq Appl. 2016;3(1). https://doi.org/10.4172/2469-9853.1000123
Atkov OY, Gorokhova SG, Sboev AG, Generozov EV, Muraseyeva EV, Moroshkina SY, Cherniy NN. Coronary heart disease diagnosis by artificial neural networks including genetic polymorphisms and clinical parameters. J Cardiol. 2012;59(2):190-194. https://doi.org/10.1016/j.jjcc.2011.11.005
Šerý O, Povová J, Balcar VJ. Perspectives in genetic prediction of Alzheimer’s disease. Neuroendocrinol Lett. 2014;35(5):359-366.